Abstract 288P
Background
The family planning program curated by the Indonesian government to limit population growth has been successful. Hormonal contraception contains progesterone and estrogen, risk factors for breast cancer. Breast cancer is a prominent health issue in Indonesia as it has a high incidence rate and accounts for the second-highest mortality in women. the purpose of this research, looking at how the effect of hormonal contraceptives on estradiol and progesterone levels in breast cancer patients.
Methods
a six-year prospective cohort study at Dr. Moewardi Hospital. There are two groups of subjects with and without hormonal contraceptives. Data on breast cancer stage, tumor characteristics, estradiol levels, and progesterone levels were collected. The data are presented in mean, standard deviation, and distribution frequency (%). Statistical tests using Chi-square, Fisher exact, Mann-Whitney, and an independent t-test.
Results
303 samples were aged 31 to 78 years. 51% grade III, 28.7% Luminal B, and 45.9% LABC. 54.1% high estradiol levels, and 80.5% normal progesterone levels. The use of contraceptives, the type, duration of use, and duration of discontinuation of contraceptives do not affect estradiol and progesterone levels (p>0.05). Estradiol levels affect PFS, DFS, and OS (p<0.05) while progesterone levels have no effect (p>0.05). The type and duration of contraceptive use do not affect PFS, DFS, and OS (p>0.05). While the duration of discontinuation of contraceptives affects the OS (p<0.05) but not PFS and DFS (p>0.05).
Conclusions
PFS, DFS, and OS in breast cancer are affected by significantly high levels of estradiol, and in contrast, progesterone levels tend to be normal and not significantly affected. Lower levels of estradiol are associated with a better OS. A shorter duration for stopping the use of contraceptives is associated with a worse OS.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
281P - Cancer-related symptoms as mediators between treatment and functional capacity in adolescents and young adults (AYAs) with cancer
Presenter: Chung Tin Justin Ma
Session: Poster viewing 04
282P - Nutritional status and nutritional therapy of common cancer in a cancer hospital of Southwest China
Presenter: Huiqing Yu
Session: Poster viewing 04
283P - Comparative analysis of osteoporotic fracture (OF) and pathologic fracture (PF) in patients with metastatic colorectal cancer (mCRC) who received palliative chemotherapy
Presenter: Yejee Lim
Session: Poster viewing 04
284P - Gut microbiota mediates the protective effects of resveratrol against the intestinal barrier dysfunction in non-alcoholic steatohepatitis induced by high-fat diet
Presenter: Haoyang Cao
Session: Poster viewing 04
285P - Reticulocyte hemoglobin equivalent as an early predictor of iron deficiency anemia in cancer patients
Presenter: Aditya Sarin
Session: Poster viewing 04
286P - Breakthrough COVID-19 infections in patients with cancer from a prospective study of COVID-19 vaccine response
Presenter: Amy Body
Session: Poster viewing 04
287P - Long-term yoga enhances the quality of life and symptomatic scale in breast cancer patients undergoing treatment
Presenter: Mayank Jain
Session: Poster viewing 04
289P - Cancer cachexia following breast cancer (BC) chemotherapy was associated with clinical stage, number of chemotherapy cycles, and vitamin D concentration
Presenter: Susanna Hutajulu
Session: Poster viewing 04
290P - Use of PEG G-CSF is associated with decreased myelotoxicity in dexrazoxane-used aggressive non-Hodgkin lymphoma patients
Presenter: Sung-Nam Lim
Session: Poster viewing 04
291P - Assessment of nutritional status in cancer patients using patient generated subjective global assessment screening tool
Presenter: Anuj K. C.
Session: Poster viewing 04